BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35702410)

  • 1. Acute leukaemia in children with Down syndrome in a low middle-income country.
    Ul-Ain R; Faizan M; Anwar S; Riaz S; Ahmad A; Zafar H; Shamim W
    Ecancermedicalscience; 2022; 16():1374. PubMed ID: 35702410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
    O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
    Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-related mortality in children with acute lymphoblastic leukaemia in a low-middle income country.
    ; Faizan M; Shamim W
    J Pak Med Assoc; 2021 Oct; 71(10):2373-2377. PubMed ID: 34974574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.
    Canfield KN; Spector LG; Robison LL; Lazovich D; Roesler M; Olshan AF; Smith FO; Heerema NA; Barnard DR; Blair CK; Ross JA
    Br J Cancer; 2004 Nov; 91(11):1866-72. PubMed ID: 15520821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.
    Salazar EG; Li Y; Fisher BT; Rheingold SR; Fitzgerald J; Seif AE; Huang YS; Bagatell R; Aplenc R
    Br J Haematol; 2016 Aug; 174(4):591-9. PubMed ID: 27161549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of myeloid leukaemia in children with Down syndrome in Ireland.
    Dowling GP; Piccin A; Gavin KT; Betts DR; Malone A; Cotter M; Sills A; Evans P; O' Marcaigh A; Smith OP
    Ir J Med Sci; 2020 Aug; 189(3):979-984. PubMed ID: 32006388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in paediatric acute myeloid leukaemia.
    Ghafoor T; Sharif I; Bashir F; Ahmed S; Ashraf T; Khalil S; Farah T
    J Pak Med Assoc; 2020 Dec; 70(12(B)):2316-2322. PubMed ID: 33475535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
    Rao A; Hills RK; Stiller C; Gibson BE; de Graaf SS; Hann IM; O'Marcaigh A; Wheatley K; Webb DK
    Br J Haematol; 2006 Mar; 132(5):576-83. PubMed ID: 16445830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukaemia survival trends in children with Down's syndrome in Great Britain, 1971-2000: a population-based study.
    Shah A; Stiller C; Lancaster D; Vincent T; Coleman MP
    J Epidemiol Community Health; 2010 Jul; 64(7):604-9. PubMed ID: 19703908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
    Blair CK; Roesler M; Xie Y; Gamis AS; Olshan AF; Heerema NA; Robison LL; Ross JA;
    Paediatr Perinat Epidemiol; 2008 May; 22(3):288-95. PubMed ID: 18426524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
    Maloney KW
    Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view.
    Hasaart KAL; Bertrums EJM; Manders F; Goemans BF; van Boxtel R
    Expert Rev Mol Med; 2021 Apr; 23():e5. PubMed ID: 33902785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
    Rajantie J; Siimes MA
    J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
    Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
    Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.
    Abildgaard L; Ellebaek E; Gustafsson G; Abrahamsson J; Hovi L; Jonmundsson G; Zeller B; Hasle H
    Ann Hematol; 2006 May; 85(5):275-80. PubMed ID: 16518605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
    Lo KC; Chalker J; Strehl S; Neat M; Smith O; Dastugue N; Kearney L; Izraeli S; Kempski H; Cowell JK
    Br J Haematol; 2008 Sep; 142(6):934-45. PubMed ID: 18557744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database.
    Morice PM; Leary A; Dolladille C; Chrétien B; Poulain L; González-Martín A; Moore K; O'Reilly EM; Ray-Coquard I; Alexandre J
    Lancet Haematol; 2021 Feb; 8(2):e122-e134. PubMed ID: 33347814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of malignant disorders in individuals with Down's syndrome.
    Hasle H
    Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.